We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnoses of Heart Scarring Improved by MR Scanning Taken During Systole Phase

By MedImaging International staff writers
Posted on 02 May 2013
Magnetic resonance imaging (MRI) taken in a patient during the cardiac cycle provide a more comprehensive outlook of the level of myocardial scarring in patients with ischemic cardiomyopathy.

Scar detection is significant because it helps identify patients who are at higher risk of a fatal event, according to Dr. James Fernandez, from the Stony Brook University Heart Institute (Stony Brook, NY, USA), and the first author of the study.

The standard protocol to determine scar in these patients is to collect just diastolic data, reported Dr. Fernandez. “However, our study of 30 patients at the University of Southern California found that images taken during the systolic cardiac phase can show scars not seen on images taken in the diastolic phase,” Dr. Fernandez said. “Scars were seen in 23 studies in diastole versus 25 studies in systole,” he said. In three studies, systolic images showed scars beneath the left ventricle, an area prone to ischemic damage, that were not detectable on diastolic images,” Dr. Fernandez explained.

The research was presented April 16, 2013, at the American Roentgen Ray Society (ARRS) annual meeting in Washington DC (USA).

Related Links:
Stony Brook University Heart Institute

X-Ray Generator
Advantage Plus Generators
New
Radiology Monitor
Barco MDNC-12130 Nio Fusion 12MP Radiology Monitor
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Medical Radiographic X-Ray Machine
TR30N HF

Channels

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.